To access this element change to forms mode OFF
Grant Award View - GA207611
Engineering chimeric antigen receptor (CAR) T cells that induce host...
GA ID:
GA207611
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$984,101.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Engineering chimeric antigen receptor (CAR) T cells that induce host anti-tumour immunity
Purpose:
This project will further enhance the therapeutic application of a gene-engineering based immune therapy involving a patients' own cells. To date this form of therapy has been effective in blood cancers but not solid tumours. We will aim to overcome this by developing technological and scientific advances which will make the immune cells more effective against solid tumours. These findings have the potential to provide treatment options for late stage solid tumour cancer patients.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012454
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA